A randomised controlled trial was conducted in 2022 investigating the impact of semaglutide and liraglutide on weight loss in individuals living with obesity
Research indicates that Pso has strong connections to metabolic syndrome and insulin resistance, while GLP-1RAs might provide anti-inflammatory benefits through the TNF- and IL-17 pathways [8,62]
Besides, GLP-1RAs might be driven by anti-inflammatory mechanisms to inhibit the formation of macrophage foam cells and thus slow down the pathological processes of AS (125, 126)
Other GLP-1 medications, such as Wegovy, are approved specifically for weight loss
I reach for something small, soft, and protein-rich like Greek yogurt, cottage cheese, a protein smoothie, or a small bowl of something warm like eggs or soup